Axio Biosolutions Private Limited, a medical device designer and manufacturer company is proud to announce that it has obtained the European Union Class III Medical Device CE mark approval for its range of Emergency Haemostatic Dressing - AXIOSTAT. The CE mark designation will allow AXIOSTAT to be sold in the European Union and other countries.
AXIOSTAT, India’s First Emergency Haemostat belongs to an advanced class of wound dressings that stops traumatic external bleeding within few minutes of application by providing an active mechanical barrier to the wound site.
AXIOSTAT is a sterile, single use, non-absorbable haemostatic dressing intended to be used for temporary control of bleeding wounds. AXIOSTAT stops moderate to severe bleeding due to cuts, abrasions, lacerations, venous or arterial bleeding. AXIOSTAT is also approved for use in India. AXIOSTAT is successfully being used by paramedics, doctors, paramilitary & army soldiers, industry workers and more. AXIOSTAT has a 3 year shelf life and is available in various sizes. This approval represents a significant milestone for Axio, as we continue to innovate and introduce affordable solutions for unmet healthcare needs.
For more information, visit www.axiostat.com.